J&J | JNJ - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.22B 329M 2026-03
Abbott USD 5.3B 380M 2026-03
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Baxter International USD 1.81B 587M 2026-03
Bayer EUR 5.23B 731M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Biogen USD 797.5M 302M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
CONMED USD 133.6M 21.31M 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.8B 195M 2026-03
Merck USD 2.94B 380M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03
Zoetis USD 672M 71M 2026-03